Cargando…

Modulation of Inflammation-Related Lipid Mediator Pathways by Celastrol During Human Macrophage Polarization

BACKGROUND AND PURPOSE: Celastrol (CS) is a major active ingredient of the Chinese/Asian herb Tripterygium wilfordii that is frequently used as phytomedicine to treat inflammation and autoimmune diseases. We showed before that short-term exposure to CS (1 µM) favorably impacts the biosynthesis of in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Kehong, Jordan, Paul Mike, Pace, Simona, Hofstetter, Robert K, Werner, Markus, Chen, Xinchun, Werz, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169975/
https://www.ncbi.nlm.nih.gov/pubmed/35676971
http://dx.doi.org/10.2147/JIR.S356964
_version_ 1784721312087801856
author Zhang, Kehong
Jordan, Paul Mike
Pace, Simona
Hofstetter, Robert K
Werner, Markus
Chen, Xinchun
Werz, Oliver
author_facet Zhang, Kehong
Jordan, Paul Mike
Pace, Simona
Hofstetter, Robert K
Werner, Markus
Chen, Xinchun
Werz, Oliver
author_sort Zhang, Kehong
collection PubMed
description BACKGROUND AND PURPOSE: Celastrol (CS) is a major active ingredient of the Chinese/Asian herb Tripterygium wilfordii that is frequently used as phytomedicine to treat inflammation and autoimmune diseases. We showed before that short-term exposure to CS (1 µM) favorably impacts the biosynthesis of inflammation-related lipid mediators (LM) in human polarized macrophages by modulating the activities of different lipoxygenases (LOXs). However, whether CS regulates the expression of LOXs and other related LM-biosynthetic enzymes during macrophage polarization is unknown. Here, we investigated how CS affects LM-biosynthetic enzyme expression on the protein level and studied concomitant LM signature profiles during polarization of human monocyte-derived macrophages (MDM) towards M1- and M2-like phenotypes. METHODS AND RESULTS: We used LM metabololipidomics to study the long-term effects of CS on LM profile signatures after manipulation of human monocyte-derived macrophages (MDM) during polarization. Exposure of MDM to low concentrations of CS (ie, 0.2 µM) during polarization to an inflammatory M1 phenotype potently suppressed the formation of pro-inflammatory cyclooxygenase (COX)- and 5-LOX-derived LM, especially prostaglandin (PG)E(2). Notably, gene and enzyme expression of COX-2 and microsomal PGE(2) synthase (mPGES)-1 as well as M1 markers were strongly decreased by CS during M1-MDM polarization, along with impaired activation of nuclear factor-κB and p38 mitogen-activated protein kinase. During IL-4-induced M2 polarization, CS decreased the capacity of the resulting M2-MDM to generate pro-inflammatory COX and 5-LOX products as well but it also reduced the formation of 12/15-LOX products and specialized pro-resolving mediators, without affecting the levels of liberated fatty acid substrates. CONCLUSION: Depending on the timing and concentration, CS not only favorably affects LOX activities in macrophages but also the expression of LM-biosynthetic enzymes during macrophage polarization connected to changes of inflammation-related LM which might be of relevance for potential application of CS to treat inflammatory disorders.
format Online
Article
Text
id pubmed-9169975
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-91699752022-06-07 Modulation of Inflammation-Related Lipid Mediator Pathways by Celastrol During Human Macrophage Polarization Zhang, Kehong Jordan, Paul Mike Pace, Simona Hofstetter, Robert K Werner, Markus Chen, Xinchun Werz, Oliver J Inflamm Res Original Research BACKGROUND AND PURPOSE: Celastrol (CS) is a major active ingredient of the Chinese/Asian herb Tripterygium wilfordii that is frequently used as phytomedicine to treat inflammation and autoimmune diseases. We showed before that short-term exposure to CS (1 µM) favorably impacts the biosynthesis of inflammation-related lipid mediators (LM) in human polarized macrophages by modulating the activities of different lipoxygenases (LOXs). However, whether CS regulates the expression of LOXs and other related LM-biosynthetic enzymes during macrophage polarization is unknown. Here, we investigated how CS affects LM-biosynthetic enzyme expression on the protein level and studied concomitant LM signature profiles during polarization of human monocyte-derived macrophages (MDM) towards M1- and M2-like phenotypes. METHODS AND RESULTS: We used LM metabololipidomics to study the long-term effects of CS on LM profile signatures after manipulation of human monocyte-derived macrophages (MDM) during polarization. Exposure of MDM to low concentrations of CS (ie, 0.2 µM) during polarization to an inflammatory M1 phenotype potently suppressed the formation of pro-inflammatory cyclooxygenase (COX)- and 5-LOX-derived LM, especially prostaglandin (PG)E(2). Notably, gene and enzyme expression of COX-2 and microsomal PGE(2) synthase (mPGES)-1 as well as M1 markers were strongly decreased by CS during M1-MDM polarization, along with impaired activation of nuclear factor-κB and p38 mitogen-activated protein kinase. During IL-4-induced M2 polarization, CS decreased the capacity of the resulting M2-MDM to generate pro-inflammatory COX and 5-LOX products as well but it also reduced the formation of 12/15-LOX products and specialized pro-resolving mediators, without affecting the levels of liberated fatty acid substrates. CONCLUSION: Depending on the timing and concentration, CS not only favorably affects LOX activities in macrophages but also the expression of LM-biosynthetic enzymes during macrophage polarization connected to changes of inflammation-related LM which might be of relevance for potential application of CS to treat inflammatory disorders. Dove 2022-06-02 /pmc/articles/PMC9169975/ /pubmed/35676971 http://dx.doi.org/10.2147/JIR.S356964 Text en © 2022 Zhang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhang, Kehong
Jordan, Paul Mike
Pace, Simona
Hofstetter, Robert K
Werner, Markus
Chen, Xinchun
Werz, Oliver
Modulation of Inflammation-Related Lipid Mediator Pathways by Celastrol During Human Macrophage Polarization
title Modulation of Inflammation-Related Lipid Mediator Pathways by Celastrol During Human Macrophage Polarization
title_full Modulation of Inflammation-Related Lipid Mediator Pathways by Celastrol During Human Macrophage Polarization
title_fullStr Modulation of Inflammation-Related Lipid Mediator Pathways by Celastrol During Human Macrophage Polarization
title_full_unstemmed Modulation of Inflammation-Related Lipid Mediator Pathways by Celastrol During Human Macrophage Polarization
title_short Modulation of Inflammation-Related Lipid Mediator Pathways by Celastrol During Human Macrophage Polarization
title_sort modulation of inflammation-related lipid mediator pathways by celastrol during human macrophage polarization
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9169975/
https://www.ncbi.nlm.nih.gov/pubmed/35676971
http://dx.doi.org/10.2147/JIR.S356964
work_keys_str_mv AT zhangkehong modulationofinflammationrelatedlipidmediatorpathwaysbycelastrolduringhumanmacrophagepolarization
AT jordanpaulmike modulationofinflammationrelatedlipidmediatorpathwaysbycelastrolduringhumanmacrophagepolarization
AT pacesimona modulationofinflammationrelatedlipidmediatorpathwaysbycelastrolduringhumanmacrophagepolarization
AT hofstetterrobertk modulationofinflammationrelatedlipidmediatorpathwaysbycelastrolduringhumanmacrophagepolarization
AT wernermarkus modulationofinflammationrelatedlipidmediatorpathwaysbycelastrolduringhumanmacrophagepolarization
AT chenxinchun modulationofinflammationrelatedlipidmediatorpathwaysbycelastrolduringhumanmacrophagepolarization
AT werzoliver modulationofinflammationrelatedlipidmediatorpathwaysbycelastrolduringhumanmacrophagepolarization